The University at Buffalo-led consortium that won a prestigious $15 million Clinical and Translational Science Award has adopted a new name and visual identity to better represent its work.
The new entity is now called the University at Buffalo Clinical and Translational Science Institute. Its collaborative partners strive to improve health and reduce health disparities in the Buffalo Niagara region by conducting and supporting research leading to new innovative medical therapies and technologies.
The new logo for the entity features the UB logo and is consistent with the university's new brand and identity strategy launched by the university in 2016.
"The change in our name to the Clinical and Translational Science Institute is a better reflection of the innovative clinical and translational work we are engaged in," said Dr. Timothy F. Murphy, a UB Department of Medicine professor and senior associate dean for translational research in the Jacobs School of Medicine and Biomedical Sciences. "It is intensely focused on groundbreaking research, new discoveries and providing patients with access to innovative new treatments and therapies."
The consortium won the $15 million award in 2015 from the National Institutes of Health.